Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34

Inclusion Criteria:

* Age \> 18 years
* Karnofsky Performance Status of \> or equal to 40%
* Patients with locally advanced or metastatic small cell or non-small cell lung cancer
* The presence of intra-thoracic symptoms requiring palliative treatment
* WBI (if required) is permitted
* The patient's condition must permit waiting for the 3-dimensional design process to be implemented. This will be at the discretion of the Consultant Physician
* Patients presenting with pleural effusions - provided the pleural effusion does not prevent the reasonably accurate delineation of the target volume
* Intra-thoracic disease requiring palliation must be clearly evident on a diagnostic CT scan
* Life expectancy of at least 3 months (assessed by clinician)
* Provision of written informed consent in line with ICH-GCP guidelines

Exclusion Criteria:

-In the opinion of the Investigator, any evidence of severe or uncontrolled systematic disease (e.g. unstable or uncompensated respiratory, cardiac, hepatic or renal disease)